These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 10590087)

  • 1. Mutagenesis of the signal sequence of yellow fever virus prM protein: enhancement of signalase cleavage In vitro is lethal for virus production.
    Lee E; Stocks CE; Amberg SM; Rice CM; Lobigs M
    J Virol; 2000 Jan; 74(1):24-32. PubMed ID: 10590087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal peptidase cleavage at the flavivirus C-prM junction: dependence on the viral NS2B-3 protease for efficient processing requires determinants in C, the signal peptide, and prM.
    Stocks CE; Lobigs M
    J Virol; 1998 Mar; 72(3):2141-9. PubMed ID: 9499070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cleavage at a novel site in the NS4A region by the yellow fever virus NS2B-3 proteinase is a prerequisite for processing at the downstream 4A/4B signalase site.
    Lin C; Amberg SM; Chambers TJ; Rice CM
    J Virol; 1993 Apr; 67(4):2327-35. PubMed ID: 8445732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inefficient signalase cleavage promotes efficient nucleocapsid incorporation into budding flavivirus membranes.
    Lobigs M; Lee E
    J Virol; 2004 Jan; 78(1):178-86. PubMed ID: 14671099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenesis of the NS2B-NS3-mediated cleavage site in the flavivirus capsid protein demonstrates a requirement for coordinated processing.
    Amberg SM; Rice CM
    J Virol; 1999 Oct; 73(10):8083-94. PubMed ID: 10482557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of the flavivirus envelope: role of the viral NS2B-NS3 protease.
    Yamshchikov VF; Compans RW
    J Virol; 1995 Apr; 69(4):1995-2003. PubMed ID: 7884844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NS2B-3 proteinase-mediated processing in the yellow fever virus structural region: in vitro and in vivo studies.
    Amberg SM; Nestorowicz A; McCourt DW; Rice CM
    J Virol; 1994 Jun; 68(6):3794-802. PubMed ID: 8189517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A flavivirus signal peptide balances the catalytic activity of two proteases and thereby facilitates virus morphogenesis.
    Lobigs M; Lee E; Ng ML; Pavy M; Lobigs P
    Virology; 2010 May; 401(1):80-9. PubMed ID: 20207389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NS2B/3 proteolysis at the C-prM junction of the tick-borne encephalitis virus polyprotein is highly membrane dependent.
    Kurz M; Stefan N; Zhu J; Skern T
    Virus Res; 2012 Sep; 168(1-2):48-55. PubMed ID: 22727684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).
    Arroyo J; Guirakhoo F; Fenner S; Zhang ZX; Monath TP; Chambers TJ
    J Virol; 2001 Jan; 75(2):934-42. PubMed ID: 11134306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the number of amino acid residues in the signal segment upstream or downstream of the NS2B-3 cleavage site on production and secretion of prM/M-E virus-like particles of West Nile virus.
    Takahashi H; Ohtaki N; Maeda-Sato M; Tanaka M; Tanaka K; Sawa H; Ishikawa T; Takamizawa A; Takasaki T; Hasegawa H; Sata T; Hall WW; Kurata T; Kojima A
    Microbes Infect; 2009 Nov; 11(13):1019-28. PubMed ID: 19647801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the transmembrane domains of prM and E proteins in the formation of yellow fever virus envelope.
    Op De Beeck A; Molenkamp R; Caron M; Ben Younes A; Bredenbeek P; Dubuisson J
    J Virol; 2003 Jan; 77(2):813-20. PubMed ID: 12502797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenesis of the yellow fever virus NS2A/2B cleavage site: effects on proteolytic processing, viral replication, and evidence for alternative processing of the NS2A protein.
    Nestorowicz A; Chambers TJ; Rice CM
    Virology; 1994 Feb; 199(1):114-23. PubMed ID: 8116234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exchanging the yellow fever virus envelope proteins with Modoc virus prM and E proteins results in a chimeric virus that is neuroinvasive in SCID mice.
    Charlier N; Molenkamp R; Leyssen P; Paeshuyse J; Drosten C; Panning M; De Clercq E; Bredenbeek PJ; Neyts J
    J Virol; 2004 Jul; 78(14):7418-26. PubMed ID: 15220415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resuscitating mutations in a furin cleavage-deficient mutant of the flavivirus tick-borne encephalitis virus.
    Elshuber S; Mandl CW
    J Virol; 2005 Sep; 79(18):11813-23. PubMed ID: 16140758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of signalase processing and induction of prM-E secretion by the flavivirus NS2B-NS3 protease: roles of protease components.
    Yamshchikov VF; Trent DW; Compans RW
    J Virol; 1997 Jun; 71(6):4364-71. PubMed ID: 9151825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenesis of conserved residues at the yellow fever virus 3/4A and 4B/5 dibasic cleavage sites: effects on cleavage efficiency and polyprotein processing.
    Lin C; Chambers TJ; Rice CM
    Virology; 1993 Feb; 192(2):596-604. PubMed ID: 8421901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Processing of flavivirus structural glycoproteins: stable membrane insertion of premembrane requires the envelope signal peptide.
    Markoff L; Chang A; Falgout B
    Virology; 1994 Nov; 204(2):526-40. PubMed ID: 7941319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction, characterization and immunogenicity of recombinant yellow fever 17D-dengue type 2 viruses.
    Caufour PS; Motta MC; Yamamura AM; Vazquez S; Ferreira II; Jabor AV; Bonaldo MC; Freire MS; Galler R
    Virus Res; 2001 Nov; 79(1-2):1-14. PubMed ID: 11551641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yellow fever virus/dengue-2 virus and yellow fever virus/dengue-4 virus chimeras: biological characterization, immunogenicity, and protection against dengue encephalitis in the mouse model.
    Chambers TJ; Liang Y; Droll DA; Schlesinger JJ; Davidson AD; Wright PJ; Jiang X
    J Virol; 2003 Mar; 77(6):3655-68. PubMed ID: 12610141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.